Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

221P - Primary and Secondary Breast Sarcoma: Clinical and Pathological Characteristics, Prognostic Factors and Nomograms for Predicting Survival

Date

04 May 2022

Session

Poster Display session

Topics

Supportive Care and Symptom Management

Tumour Site

Breast Cancer

Presenters

Salma Fala

Citation

Annals of Oncology (2022) 33 (suppl_3): S224-S231. 10.1016/annonc/annonc895

Authors

S. Fala

Author affiliations

  • Suez Canal University - Faculty of Medicine, Ismailia/EG

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 221P

Background

Breast sarcoma is a rare type of breast tumor with different features and outcomes compared to carcinoma. Our study aims to describe the clinical and pathological characteristics of primary breast sarcoma (PBS) and secondary breast sarcoma (SBS) along with determining prognostic factors and developing nomograms for predicting survival.

Methods

Using the Surveillance, Epidemiology, and End Results (SEER) Program, female patients diagnosed with breast sarcoma between 1975 and 2016 were identified. Cox regression was used to evaluate the association between survival and clinical features. Nomograms for predicting survival of PBS and SBS were created based on significant factors in the multivariable Cox regression analysis and were evaluated using 10-fold-cross-validation.

Results

We included 1334 patients (816 PBS and 518 SBS). K-Meier survival analysis showed that PBS had a significant better OS than SBS (107 months for PBS and 45 for SBS). Cox regression showed worse survival of patient with PBS who were > 60 years (HR 3.04, 95% CI 2.46-3.74), had tumor size > 50 mm (HR 2.01, 95% CI 1.61-2.51). The same factors were also associated with significantly worse survival of SBS patients including age > 60 years (HR 2.00, 95% CI 1.42-2.82), tumor size > 50 mm (HR 1.72, 95% CI 1.35-2.21), with addational factor which is being not married (HR 1.50, 95% CI 1.19-1.90). Surgery was associated with better overall survival for PBS (HR 0.60, 95% CI 0.42-0.85) and SBS (HR 0.46, 95% CI 0.31-0.68). C-indexes of created nomograms were 0.73 for PBS and 0.69 for SBS. Multivariable Cox Proportional Hazard for OS. Table: 221P

PBS SBS
HR 95% CI P-value HR 95% CI P-Value
Age Age
>60 years Ref. <60 years Ref.
>60 years 3.04 2.46-3.74 <0.005 >60 years 2.00 1.42-2.82 <0.005
Metastasis Marital Status
M0 Ref. Married Ref.
M+ 5.24 3.67-7.49 <0.005 Not married 1.50 1.19-1.90 <0.005
Tumor Size Metastasis
< 50 mm Ref. M0 Ref.
>50 mm 2.01 1.61-2.51 <0.005 M+ 3.24 2.03-5.15 <0.005
Surgery Tumor Size
No Ref. <50 mm Ref.
Yes 0.60 0.42-0.85 <0.005 >50 mm 1.72 1.35-2.21 <0.005
Chemotherapy Surgery
No/Unknown Ref. No Ref.
Yes 1.21 0.94-1.55 0.14 Yes 0.46 0.31-0.68 <0.005

Conclusions

PBS had a better OS compared to SBS with hemangiosarcoma being the most common histologic subtype. Age, tumor size, and metastasis were the most important prognostic factors for the survival of PBS and SBS. Surgery was associated with better overall survival. However, radiation and chemotherapy did not show significant improvement in survival.

Legal entity responsible for the study

The author.

Funding

Has not received any funding.

Disclosure

The author has declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.